Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

COVID-19

Discovery & Development COVID-19

Pharma Versus Omicron

| Stephanie Sutton

How will vaccine and therapeutic makers respond to the new SARS-CoV-2 variant?

Discovery & Development Drug Discovery

The Next Frontier in HIV Prevention

| Maryam Mahdi

Exploring the potential of vaccines for treatment equity.

Business & Regulation COVID-19

R&R for an Anti-COVID Europe

| Angus Stewart

The EMA has given the nod to Ronapreve and Regkirona, two monoclonal antibody treatments for COVID-19.

Manufacture Facilities

Swimming with the mRNA Current

| Bill Jarvis

How RNA is making waves in the industry – and leading to new research projects and increased demand for new manufacturing capacities.

Business & Regulation COVID-19

Astra-Amplifiers

| Angus Stewart

Setting its sights on self-amplifying RNA, AstraZeneca has signed a deal with Imperial College London spinoff VaxEquity.

Manufacture Contract Manufacturing Services

Weathering the Storm Together - Part 1

| Stephanie Sutton

The efforts of CDMOs have been absolutely crucial in the pandemic response. We ask five CDMO gurus how they reacted to COVID-19.

Manufacture Contract Manufacturing Services

Weathering the Storm Together - Part 2

| Stephanie Sutton

Part 2 of our roundtable discussion with CDMOs covers outsourcing preferences, the demand for mRNA, and more.

Discovery & Development Clinical Trials

Taking the Trial to the Patient

| Stephanie Sutton

The way the pharma industry has traditionally handled clinical trials does not make participation easy.

Manufacture Facilities

Giving It All We’ve Got: Lessons Learned from Operation Warp Speed

| Jarrod Wrampe, Charles Heffernan

What lessons were learned from Operation Warp Speed?

Discovery & Development COVID-19

A Moonshot for COVID-19

| Angus Stewart

Meet the international coalition working to tackle COVID-19 in low- and middle-income countries.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register